Difference between revisions of "Communications Committee"
m (→Current Work) |
|||
| (14 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{TOCright}} | {{TOCright}} | ||
:Chairs: Anne M. Smith, PhD; Majid Chalian, MD | :Chairs: Anne M. Smith, PhD; Majid Chalian, MD | ||
| − | |||
* [https://docs.google.com/spreadsheets/d/1w-kGTqObvK-mVtjja1d-Yxs9fwNZnAZmdwUklB2zvBc/edit#gid=1807281004 Roster] | * [https://docs.google.com/spreadsheets/d/1w-kGTqObvK-mVtjja1d-Yxs9fwNZnAZmdwUklB2zvBc/edit#gid=1807281004 Roster] | ||
| Line 27: | Line 26: | ||
'''Approved call summaries:''' | '''Approved call summaries:''' | ||
| − | *[[Media: | + | *[[Media:2023_06_30_QCC_Call_Summary-FINAL.pdf | June 30, 2023]] |
| + | *[[Media:2023_05_05_QCC_Call_Summary-FINAL-AMS.pdf | May 5, 2023]] | ||
| + | *[[Media:2023_03_24_QCC_Call_Summary-FINAL-AMS.pdf | March 24, 2023]] | ||
| + | *[[Media:2023_01_27_QCC_Call_Summary-FINAL.pdf | January 27, 2023]] | ||
| + | *[[Media:2022_10_28_QCC_Call_Summary-FINAL-AMS.pdf | October 28, 2022]] | ||
| + | *[[Media:2022_09_30_QCC_Call_Summary-FINAL-AMS.pdf | September 30, 2022]] | ||
| + | *[[Media:2022_08_26_QCC_Call_Summary-FINAL-AMS.pdf | August 26, 2022]] | ||
| + | *[[Media:2022_07_08_QCC_Call_Summary-FINAL.pdf | July 8, 2022]] | ||
| + | *[[Media:2022_05_20_QCC_Call_Summary-FINAL.pdf | May 20, 2022]] | ||
| + | *[[Media:2022_04_29_QCC_Call_Summary-FINAL.pdf | April 29, 2022]] | ||
*[[Media:2022_03_18_QCC_Call_Summary-FINAL.pdf | March 18, 2022]] | *[[Media:2022_03_18_QCC_Call_Summary-FINAL.pdf | March 18, 2022]] | ||
*[[Media:2022_02_18_QCC_Call_Summary-FINAL.pdf | February 18, 2022]] | *[[Media:2022_02_18_QCC_Call_Summary-FINAL.pdf | February 18, 2022]] | ||
| Line 40: | Line 48: | ||
==Current Work== | ==Current Work== | ||
| + | QIBA Videos are now posted to RSNA's YouTube Channel! https://tinyurl.com/QIBA-YouTube-Playlist. These videos have been created by our QIBA volunteers. Learn more about RSNA’s Quantitative Imaging Biomarkers Alliance® (QIBA), which unites researchers, health care professionals and industry to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice. https://lnkd.in/gzyf8ees | ||
| + | |||
| + | Please note: All QIBA promotional materials need to be reviewed and approved by QIBA Leadership or the QIBA Communications Committee. | ||
Latest revision as of 16:46, 17 January 2024
- Chairs: Anne M. Smith, PhD; Majid Chalian, MD
Communications Committee Mission Statement
QIBA Communications will educate and publicize the impact of image quantification on therapeutic clinical trials and on patient diagnosis, staging and follow-up.
- Oversee educational component
Scope
The Communications Committee supports QIBA Biomarker Committees by providing visibility to QIBA efforts.
QIBA Community
A QIBA Community has been set up via the Higher Logic platform on RSNA web pages to encourage continuing dialogue among QIBA members and across modalities. Instructions are available here:
Meetings/Call Summaries
Monthly Tcons (Contact Julie for details)
Approved call summaries:
- June 30, 2023
- May 5, 2023
- March 24, 2023
- January 27, 2023
- October 28, 2022
- September 30, 2022
- August 26, 2022
- July 8, 2022
- May 20, 2022
- April 29, 2022
- March 18, 2022
- February 18, 2022
- January 28, 2022
QIBA Communications Committee Call Summaries Archive
Working Documents
Current Work
QIBA Videos are now posted to RSNA's YouTube Channel! https://tinyurl.com/QIBA-YouTube-Playlist. These videos have been created by our QIBA volunteers. Learn more about RSNA’s Quantitative Imaging Biomarkers Alliance® (QIBA), which unites researchers, health care professionals and industry to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice. https://lnkd.in/gzyf8ees
Please note: All QIBA promotional materials need to be reviewed and approved by QIBA Leadership or the QIBA Communications Committee.